Page 51 - GTM-2-1

Global Translational Medicine Inflammatory and anti-inflammatory responses in HTLV1

emerge as a putative immunoregulatory mechanism to infected cell lines. Acta Virol, 66: 127–138.
counterbalance the monocyte‐derived TNF‐α and guarantee https://doi.org/10.4149/av_2022_202
asymptomatic clinical status during chronic HTLV‐I
infection. Clin Exp Immunol, 147: 35–44. 62. Nakao Y, Koizumi T, Matsui T, et al., 1987, Effect of 1α,
25-dihydroxyvitamin D3 on proliferation of activated T-cells
https://doi.org/10.1111/j.1365-2249.2006.03252.x
and established human lymphotropic virus Type I-positive
56. De Sá KS, Santana BB, de Souza Ferreira TC, et al., 2016, T-cell lines. J Natl Cancer Inst, 78: 1079–1086.
IL28B gene polymorphisms and Th1/Th2 cytokine levels 63. Reichel H, Koeffler HP, Norman AW, 1987,
might be associated with HTLV-associated arthropathy. 25-Hydroxyvitamin D3 metabolism by human
Cytokine, 77: 79–87.
T-lymphotropic virus-transformed lymphocytes. J Clin
https://doi.org/10.1016/j.cyto.2015.11.004 Endocrinol Metab, 65: 519–526.
57. Sasada A, Takaori-Kondo A, Shirakawa K, et al., 2005, https://doi.org/10.1210/jcem-65-3-519
APOBEC3G targets human T-cell leukemia virus Type 1. 64. Koizumi T, Nakao Y, Kawanishi M, et al., 1989, Suppression
Retrovirology, 2: 32.
of c T, Fujita T M, by human T-lymphotropic virus-
https://doi.org/10.1186/1742-4690-2-32 transformed lymphocytes. hed huma. Int J Cancer,
44: 701–706.
58. Best I, López G, Verdonck K, et al., 2009, IFN‐gamma
production in response to tax 161-233, and frequency https://doi.org/10.1002/ijc.2910440425
of CD4+ Foxp3+ and Lin-HLA‐DRhigh CD123+ cells, 65. Inoue D, Matsumoto T, Ogata E, et al., 1993, 22-Oxacalcitriol,
discriminate HAM/TSP patients from asymptomatic a noncalcemic analogue of calcitriol, suppresses both cell
HTLV‐1‐carriers in a Peruvian population. Immunology, proliferation and parathyroid hormone-related peptide
128(1 Suppl): e777–e86.
gene expression in human T cell lymphotrophic virus,
https://doi.org/10.1111/j.1365-2567.2009.03082.x Type I-infected T cells. J Biol Chem, 268: 16730–16736.
59. Araújo AQ, Leite AC, Lima MA, et al., 2009, HTLV-1 and 66. Elstner E, Lee Y, Hashiya M, et al., 1994, 1 alpha,
neurological conditions: When to suspect and when to order 25-Dihydroxy-20-epi-Vitamin D3: an extraordinarily
a diagnostic test for HTLV-1 infection? Arq Neuropsiquiatr, potent inhibitor of leukemic cell growth in vitro. Blood,
67: 132–138. 84: 1960–1967.
https://doi.org/10.1590/s0004-282x2009000100036 https://doi.org/10.1182/blood.V84.6.1960.1960
60. Castro-Costa CM, de Queiroz Campos Araújo A, 67. Peter SA, Cervantes JF, 1995, Hypercalcemia associated with
Câmara CC, et al., 2009, Pain in tropical spastic paraparesis/ adult T-cell leukemia/lymphoma (ATL). J Natl Med Assoc,
HTLV-I associated myelopathy patients. Arq Neuropsiquiatr, 87: 746.
67: 866–870.
68. Masutani H, Ueda S, Yodoi J, 2005, The thioredoxin system
https://doi.org/10.1590/s0004-282x2009000500016 in retroviral infection and apoptosis. Cell Death Differ,
2: 991–998.
61. Huang Q, Ling Z, Wang H, et al., 2022, Evaluation of the
effects of 1, 25VitD3 on Th17 cells and Tregs in HTLV-1 https://doi.org/10.1038/sj.cdd.4401625

Volume 2 Issue 1 (2023) 8 https://doi.org/10.36922/gtm.v2i1.67